216 related articles for article (PubMed ID: 15262759)
21. Swallowing after major surgery of the oral cavity or oropharynx: a prospective and longitudinal assessment of patients treated by microvascular soft tissue reconstruction.
Borggreven PA; Verdonck-de Leeuw I; Rinkel RN; Langendijk JA; Roos JC; David EF; de Bree R; Leemans CR
Head Neck; 2007 Jul; 29(7):638-47. PubMed ID: 17274054
[TBL] [Abstract][Full Text] [Related]
22. Split course hyperfractionated accelerated radio-chemotherapy (SCHARC) for patients with advanced head and neck cancer: influence of protocol deviations and hemoglobin on overall survival, a retrospective analysis.
Stadler P; Putnik K; Kreimeyer T; Sprague LD; Koelbl O; Schäfer C
BMC Cancer; 2006 Dec; 6():279. PubMed ID: 17150114
[TBL] [Abstract][Full Text] [Related]
23. Multimodal intensification regimens for advanced, resectable, previously untreated squamous cell cancer of the oral cavity, oropharynx, or hypopharynx: a 12-year experience.
Schuller DE; Ozer E; Agrawal A; Grecula JC; Rhoades CA; Young DC
Arch Otolaryngol Head Neck Surg; 2007 Apr; 133(4):320-6. PubMed ID: 17438244
[TBL] [Abstract][Full Text] [Related]
24. Speech and swallowing impairment after treatment for oral and oropharyngeal cancer.
Suarez-Cunqueiro MM; Schramm A; Schoen R; Seoane-Lestón J; Otero-Cepeda XL; Bormann KH; Kokemueller H; Metzger M; Diz-Dios P; Gellrich NC
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1299-304. PubMed ID: 19075126
[TBL] [Abstract][Full Text] [Related]
25. Long-term results of a multimodal intensification regimen for previously untreated advanced resectable squamous cell cancer of the oral cavity, oropharynx, or hypopharynx.
Ozer E; Grecula JC; Agrawal A; Rhoades CA; Young DC; Schuller DE
Laryngoscope; 2006 Apr; 116(4):607-12. PubMed ID: 16585867
[TBL] [Abstract][Full Text] [Related]
26. French multicenter phase III randomized study testing concurrent twice-a-day radiotherapy and cisplatin/5-fluorouracil chemotherapy (BiRCF) in unresectable pharyngeal carcinoma: Results at 2 years (FNCLCC-GORTEC).
Bensadoun RJ; Bénézery K; Dassonville O; Magné N; Poissonnet G; Ramaïoli A; Lemanski C; Bourdin S; Tortochaux J; Peyrade F; Marcy PY; Chamorey E; Vallicioni J; Seng H; Alzieu C; Géry B; Chauvel P; Schneider M; Santini J; Demard F; Calais G
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):983-94. PubMed ID: 16376489
[TBL] [Abstract][Full Text] [Related]
27. Hyperfractionated accelerated radiotherapy in combination with weekly cisplatin for locally advanced head and neck cancer.
Beckmann GK; Hoppe F; Pfreundner L; Flentje MP
Head Neck; 2005 Jan; 27(1):36-43. PubMed ID: 15459918
[TBL] [Abstract][Full Text] [Related]
28. Intensification regimen for advanced-stage resectable hypopharyngeal carcinoma.
Ozer E; Grecula JC; Agrawal A; Rhoades CA; Schuller DE
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):385-9. PubMed ID: 16618907
[TBL] [Abstract][Full Text] [Related]
29. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
30. Dosimetric factors associated with long-term dysphagia after definitive radiotherapy for squamous cell carcinoma of the head and neck.
Caudell JJ; Schaner PE; Desmond RA; Meredith RF; Spencer SA; Bonner JA
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):403-9. PubMed ID: 19467801
[TBL] [Abstract][Full Text] [Related]
31. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
[TBL] [Abstract][Full Text] [Related]
32. Risk factors predicting aspiration after free flap reconstruction of oral cavity and oropharyngeal defects.
Smith JE; Suh JD; Erman A; Nabili V; Chhetri DK; Blackwell KE
Arch Otolaryngol Head Neck Surg; 2008 Nov; 134(11):1205-8. PubMed ID: 19015452
[TBL] [Abstract][Full Text] [Related]
33. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
34. Prospective subjective evaluation of swallowing function and dietary pattern in head and neck cancers treated with concomitant chemo-radiation.
Agarwal J; Dutta D; Palwe V; Gupta T; Laskar SG; Budrukkar A; Murthy V; Chaturvedi P; Pai P; Chaukar D; D'Cruz AK; Kulkarni S; Kulkarni A; Baccher G; Shrivastava SK
J Cancer Res Ther; 2010; 6(1):15-21. PubMed ID: 20479541
[TBL] [Abstract][Full Text] [Related]
35. [Assessment of different variants of hyperfractionated irradiation in cancer of the naso- and oropharynx and of the oral mucosa].
Aliev BM; Chuprik-Malinovskaia TP; Aleknavichius EE
Med Radiol (Mosk); 1988 Jun; 33(6):37-41. PubMed ID: 3386429
[TBL] [Abstract][Full Text] [Related]
36. Hyperfractionated-accelerated radiotherapy followed by radical surgery in locally advanced tumors of the oral cavity.
Hoeller U; Biertz I; Flinzberg S; Tribius S; Schmelzle R; Alberti W
Strahlenther Onkol; 2006 Mar; 182(3):157-63. PubMed ID: 16520910
[TBL] [Abstract][Full Text] [Related]
37. The effect of hyperbaric oxygen therapy on quality of life in oral and oropharyngeal cancer patients treated with radiotherapy.
Gerlach NL; Barkhuysen R; Kaanders JH; Janssens GO; Sterk W; Merkx MA
Int J Oral Maxillofac Surg; 2008 Mar; 37(3):255-9. PubMed ID: 18262761
[TBL] [Abstract][Full Text] [Related]
38. Swallowing-related quality of life after head and neck cancer treatment.
Gillespie MB; Brodsky MB; Day TA; Lee FS; Martin-Harris B
Laryngoscope; 2004 Aug; 114(8):1362-7. PubMed ID: 15280708
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcomes of IMRT for breast cancer: a single-institution cohort analysis.
McDonald MW; Godette KD; Butker EK; Davis LW; Johnstone PA
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1031-40. PubMed ID: 18440727
[TBL] [Abstract][Full Text] [Related]
40. Accelerated hyperfractionated radiotherapy and concomitant chemotherapy in small cell lung cancer limited-disease. Dose response, feasibility and outcome for patients treated in western Sweden, 1998-2004.
Hallqvist A; Rylander H; Björk-Eriksson T; Nyman J
Acta Oncol; 2007; 46(7):969-74. PubMed ID: 17851846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
